CVS vs SCL · P/E 16, rev $402.07B vs P/E 22, rev $2.18B
CVS Health Corp (CVS) versus Stepan Company (SCL) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Stepan Company (SCL) is a specialty chemicals company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported SCL revenue for 2024-12-31 was $2.18B. Net income was $50.4M. Revenue was down 6.3% from 2023-12-31 to 2024-12-31. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. SCL currently screens at market cap $1.29B and trailing P/E 22.3.
Not investment advice. Open the CVS and SCL stock pages for the full models.
Not investment advice.